Author

Yuzhe Shi

Columbia University Irving Medical CenterORCID 0009-0009-8483-0418Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1

Frequent Co-Authors

Alistair A. PolliD· 1 shared Andreas E. KulozikiD· 1 shared Beat C. BornhauseriD· 1 shared Frederik W. van DelftiD· 1 shared Jean‐Pierre BourquiniD· 1 shared Julie A. E. IrvingiD· 1 shared Kerstin Katharina RauwolfiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alistair A. PollORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 4, 2025

Phospho 394Y LCK flow-cytometry readout predicts dasatinib sensitivity in paediatric T-cell acute lymphoblastic leukaemia

Alistair A. Poll, Yuzhe Shi, Kerstin Katharina Rauwolf…·Frederik W. van Delft

The paper identifies phospho-LCK (pY394) as a biomarker for dasatinib sensitivity in paediatric T-ALL using flow-cytometry, showing strong correlation with drug response.

DOI 10.1101/2025.11.04.684929

humanflow cytometry

𝕏 PostBluesky